Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 (Project continuation of approved project no 91)

Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 (Project continuation of approved project no 91) is an OpenSAFELY project from Bennett Institute. Every time a researcher runs their analytic code against patient data, it is audited in public here.